UnitedHealth Group (NYSE: UNH) 在2024年第三季度财报电话会议上重申了全年盈利展望，尽管面临Medicare费率削减和Medicaid会员资格重新认定等挑战。公司报告了强劲增长，在商业产品中服务超过200万新消费者，并通过Optum Rx完成了16亿次处方配药。 UnitedHealth Group报告第三季度表现强劲，首席执行官Andrew Witty强调了公司的 ...

UnitedHealth Group's stock fell 8.1% despite beating Q3 estimates due to conservative 2024 and 2025 EPS guidance. Find out ...

UnitedHealth Group reported $6 billion in third quarter earnings that helped overcome costs of a cyberattack earlier this ...

UnitedHealth Group delivered a profit beat for the quarter, but not the kind that investors wanted to see. Heard on the ...

The company also trimmed the higher end of its 2024 adjusted profit forecast by 25 cents to $27.75 per share, partially due ...

Good morning, and welcome to the UnitedHealth Group's third-quarter 2024 earnings conference call. A question-and-answer ...

UnitedHealth Group stock fell more than 8% in early trading Tuesday as the Minnesota-based health care giant reported higher ...

UNH's third-quarter earnings benefit on the back of client wins in the Optum Rx sub-unit, partly offset by an elevated ...

UnitedHealth Group reported increased revenue, but also noted some cyberattack challenges that ended up affecting full-year ...

UnitedHealth Group kicked off another round of earnings calls for major health insurance companies on Tuesday morning, where ...

UnitedHealth Group (UNH) stock is down more than 9% in early trading Tuesday, dragging the price-weighted Dow Jones ...

Medical costs continue to surge more than expected for health insurers.